Show
Sort by
-
Characterising normal patterns of alanine aminotransferase elevations in ursodeoxycholic acid-treated patients with primary biliary cholangitis
-
Second-line therapy is indicated in ursodeoxycholic acid-treated patients with primary biliary cholangitis and high alkaline phosphatase despite a complete globe-score response
-
Optimising trial design in late-stage primary biliary cholangitis : evaluating options for composite clinical endpoint studies
-
Ursodeoxycholic acid treatment-induced globe score changes are associated with liver transplantation-free survival in patients with primary biliary cholangitis
-
Derivation of a machine learning model to predict clinical outcome in patients with primary biliary cholangitis